BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Eva Fortea Verdejo does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 RCUSArcus Biosciences Inc | Buy | $26.00 | May 2025 | +180.7% | Hit |
 BCAXBicara Therapeutics Inc. Common Stock | Sell | $8.00 | Apr 2025 | −75.6% | Hit |
 XNCRXencor Inc | Buy | $33.00 | Feb 2025 | −22.8% | Miss |
| XNCRXencor Inc | Buy | $37.00 | Dec 2024 | −42.5% | Miss |
 KNSAKiniksa Pharmaceuticals Ltd | Buy | $34.00 | May 2024 | +39.7% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.